These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1370 related articles for article (PubMed ID: 25662779)

  • 21. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Takagi H; Ando T; Umemoto T;
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):697-709. PubMed ID: 28799701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.
    Davierwala PM; Mohr FW
    Curr Atheroscler Rep; 2014 Dec; 16(12):461. PubMed ID: 25344743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.
    Qiao Y; Ma C; Nie S; Liu X; Kang J; Lv Q; Du X; Hu R; Zhang Y; Jia C; Liu X; Dong J; Chen F; Zhou Y; Lv S; Huang F; Gu C; Wu X
    Clin Cardiol; 2009 Aug; 32(8):E24-30. PubMed ID: 19455692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
    Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E
    Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies.
    Zimarino M; Corazzini A; Ricci F; Di Nicola M; De Caterina R
    JACC Cardiovasc Interv; 2013 Jul; 6(7):687-95. PubMed ID: 23769650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous coronary intervention of unprotected left main coronary artery disease: procedural strategies and technical considerations.
    Lee MS; Stone GW; Park SJ; Teirstein P; Moses J; Colombo A; Kandzari DE
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):812-22. PubMed ID: 21793172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts.
    Fortuna D; Nicolini F; Guastaroba P; De Palma R; Di Bartolomeo S; Saia F; Pacini D; Grilli R; ;
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e16-24. PubMed ID: 23628951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis.
    Tsuneyoshi H; Komiya T; Kadota K; Shimamoto T; Sakai J; Hiraoka T; Wada K; Kaneko H; Fujimoto Y; Furuichi Y; Hata R; Jinno T; Tominaga O
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):462-468. PubMed ID: 28874027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
    Li X; Kong M; Jiang D; Dong A
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.